Placebo + Donanemab

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Placebo + Donanemab
Treatment and conditionWhere it standsTrials
Placebo + Donanemab for alzheimer diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1